November 22, 2024

Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology

Deep Bio: Integrating Deep Bio's DeepDx Prostate Algorithm into PathAI's AISight IMS Platform SEOUL, SOUTH KOREA, November 19, 2024 /EINPresswire.com/ -- Deep Bio, a leader in artificial intelligence for digital pathology, announced a collaboration to integrate its...

recent articles

Proscia Concentriq integration will help Provantis users drive GLP and non-regulated toxicologic pathology studies PHILADELPHIA – June 17, 2024 – Instem, a leading provider of IT solutions and services to the global life sciences...

TORONTO, June 13, 2024 (Newswire.com) - Pathcore Inc., a leader in digital pathology software solutions, is pleased to announce a strategic partnership with Instem, a leading provider of IT solutions and services to the global life sciences...

Corista and Aira Matrix are teaming up at the 2024 Digital Pathology and Artificial Intelligence Congress (DPAIC) in San Diego to present their complementary solutions for image management and integrated AI quality control (QC). Together,...

PathAI remains an independent company, focused on developing innovative AI and digital pathology solutions SECAUCUS, N.J. and BOSTON, June 11, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information...

NEW YORK – Cota, PreciseDx, and Baptist Health South Florida on Wednesday said they are collaborating to validate PreciseDx's PreciseBreast test to predict the likelihood of invasive breast cancer recurrence. Cota, which is based in...

Aiosyn, a medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, recently conducted a clinical performance study in collaboration with Radboud university medical center. This study evaluated the...

OR

platinum partners

gold partners

Silver Partners

Media Partners